Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
ADITECH
ADITECH
 
Type
Foundation
Private entity
Contact
.
Province: NAVARRA
Phone: 34 948 29 31 30
Mobile Phone: 34 626 32 89 51
Fax: 34 948 29 29 10
info@aditechcorp.com
http://aditechcorp.com
Activity
ADItech (Advanced Innovation and Technology Corporation) is a private entity that brings together Navarre technology centres in the fields of Energy, Industry, Agri-food and Biomedicine, with a clear international vocation. The new structure, which will be coordinated by a private foundation, was created to make it more competitive, efficient and self-sustaining network that has 850 researchers and an annual income of 70 million euros.
Centres that form part of ADItech Technology Corporation:
- CNTA (National Centre for Technology and Food Safety)
- CIMA (Center of Applied Medical Research-University of Navarre)
- Navarrabiomed-Fundación Miguel Servet (Biomedical Research Center)
- CENER (National Renewable Energy Centre)
- CEMITEC (Multidisciplinary Center for Industrial Technology)
These centers are characterized by performing applied R&D projects, very close to the market, due to their close relationship with the companies. And the proof is that the board of the ADITECH Foundation is formed not only by the Government of Navarra and universities but also by leading companies in different industrial sectors such as the case of Iberdrola, Gamesa, KYB, Humanity at Work-Mondragón, M . Towers, Acciona Energy, Jofemar, Natural Gas, Cinfa, AN Group, General Mills, Group Riberebro, Ingeteam, BSH, Viscofan, Iparlat, Florette and Volkswagen, among others.
The main objective of ADItech is to become a European and global benchmark in the technologies it incorporates, seeking differentiation in specific fields of excellence, combining industrial interests and the major research lines drawn by the European Union for Horizon 2020.
AGRO-FOOD
1. FOOD INGREDIENTS
2. PRODUCT & PROCESS DEVELOPMENT. NOVEL PACKAGING
3. NOVEL FOOD PROCESSING
4. INDUSTRIAL BIOTECHNOLOGY
5. SUSTAINABLE FOOD PRODUCTION
BIO-MEDICINE
1- GENE THERAPY AND HEPATOLOGY
2- CARDIOVASCULAR SCIENCES
3- NEUROSCIENCES
4- ONCOLOGY
5- MENTAL HEALTH
6- PATHOLOGY OF LARGE SYSTEMS
7- MOLECULAR BIOLOGY, CYTOGENETICS, CELL CULTURE, IMMUNOHISTOCHEMISTRY
8- EPIDEMIOLOGICAL SURVEILLANCE
9- EPIGENETICS, PROTEOMICS AND BIOBANK BRAIN
RENEWABLE ENERGIES
4.BIOMASS ENERGY
INDUSTRY:
1.MECHANICS
2.MATERIALS
a).Materials Characterization: Technical assistance in Polymeric and Metallic materials
b).Development of functional nano-materials: Functional biopolymers. Inks and coatings.
c).Industrial waste reuse and recycling: Rubbers and reinforced polymers, Inorganic sludges and Food waste.
d).Bio-fuels development and characterisation
3.MATERIALS DEPOSITION
4.ELECTRONICS
CIMA
1-Gene Therapy and Hepatology (early liver failure markers)
This Division is devoted to the study of the mechanisms underlying liver diseases and to the development of new therapeutic and diagnostic strategies. The focus is on chronic hepatitis, liver cirrhosis, biliary disorders and liver cancer. Special attention is paid to the application of gene therapy tools to treat hepatic disorders including hepatocellular carcinoma, viral hepatitis, metabolic diseases and liver cirrhosis. Immunotherapy of chronic viral hepatitis and liver cancer and application of biochemical tests for the detection of liver fibrosis and hepatic tumors are also areas of interest
2- Cardiovascular Sciences (taking care of hypertensive heart disease)
Research in the Cardiovascular Sciences Division focuses on identifying substances present in the blood which can help in the early diagnosis of people at risk for heart failure and myocardial infarction, as well as strokes, so that they can be treated in time to prevent complications. Scientists in this division are studying molecules which play a role in the deterioration of heart function in patients with high blood pressure, and in the complication of a plaque in patients with atherosclerosis. The ultimate goal is to guide treatment and to develop new, more effective drugs that prevent or reduce the complications arising from these conditions. The studies are mainly applied to patients with metabolic syndrome, —which has reached epidemic proportions in our society— who are already at high risk for cardiovascular disease.
An emerging line of investigation focuses on stem cells harbored in the heart, capable of regenerating large amounts of functional myocardium, which points to new opportunities for myocardial repair in cardiac patients
3- Neurosciences (treatments for alzheimer’s and parkinson’s disease )
Scientists working in the Neurosciences Division study the genetic basis of neuronal death in the brains of Alzheimer’s patients, the cellular mechanisms involved and the origin of memory loss in these patients. They are also working to discover methods for early diagnosis in people with mild cognitive disorder, which may lead to finding more effective treatments.
The laboratories devoted to Parkinson’s disease explore new therapeutic approaches, including therapies that use adult stem cells and trophic factors to promote neuronal regeneration and differentiation. In clinical research, deep brain stimulation is useful for parkinsonian patients who do not respond to other types of treatment.
4- Oncology (screening and treatment for cancer)
Two main fields of research in the Oncology Division are lung cancer and blood cancers (leukaemia and lymphoma). In the case of lung cancer, the aim is to find out how tumors develop from the very first moment until they become capable of invading other organs. In cooperation with the lung cancer program at the University Clinic of Navarra, researchers are working towards the development of new molecular tests to be used in early detection programs. Also, the hemato-oncology laboratories are exploring new treatments to correct genetic disorders in leukaemia and lymphoma and are working to produce vaccines against lymphoma, for use in clinical trials on patients. Other projects are focused on the isolation of stem cells from adult tissues, and their use in different debilitating and incurable illnesses.
Scientists are also working to improve diagnosis and predict the response to treatment in cases of prostate, breast and colon cancer. They are looking for new therapies which attack specific molecular targets to fight these tumors.
This division belongs to the EU research project on «Early Lung Cancer», within the international i-ELCAP project for the early detection of lung cancer.
NAVARRABIOMED
The Public Health System of Navarra is formed by 10.000 Employees. 2,000 of then are doctors and 3,700 medical graduates. 77% of the staff works in specialized care and 20% in primary care.
This personal works in a Hospital (Hospital of Navarra in Pamplona), two community hospitals: Hospital Reina Sofía in Tudela and Hospital García Orcoyen in Estella, 54 Health centers and 243 clinics.
The Public Health Research in Navarra is development by Navarrabiomed, a Biomedical Research Center located on the grounds of the Hospital of Navarra. The center is part of the Miguel Servet Foundation
Navarrabiomed is formed by 27 groups with a total participation of 296 professionals
38 ongoing research projects
About 150 clinical research projects (clinical and observational trials) with 350 patients included
• Facilities include three technology platforms: Genomics, Proteomics and Biobank, GMP facilities, animal facilities and experimental
• Navarrabiomed is organized into five research areas:
• Neurology,
• Oncology,
• Pathology of large systems and new developments,
• Mental Health and Epidemiological Surveillance,
• Public Health and Health Services.
Link to web page: http://www.navarrabiomed.es
CNTA
The National Centre for Food Technology and Safety (CNTA) is a private non-profit Technology Centre set up in 1981 at the initiative of the agrifood companies in the Ebro valley.
The main aim of CNTA is to contribute to the development and innovation of the agrifood sector, offering technical support to improve their quality and competitiveness.
The Centre provides advanced technological services to companies and organisations requiring external support for conducting technical activities like:
 Research and development
 Quality control
 Food safety
 Training in agrifood-related topics.
LINE 1. FOOD INGREDIENTS
Obtaining value-added bioactive compounds and ingredients based on natural extracts from agro-industrial by-products.
Different technologies and methods available are the extraction, characterization, purification of bioactive compounds. Available technologies and capabilities: supercritical fluid extraction, pulse electric fields (PEF), rapid extraction and purification methods: preparative chromatography and membrane technology.
Micro- and nano- encapsulation technologies for stabilisation and delivery of technological additives and ingredients into complex food systems. Controlled release of bioactive compounds can be achieved, thus increasing their bioavailability. Spray-drying, spray-chilling, extrusion, coacervation, molecular inclusion and molecular self-assembly.
CNTA is co-owner of several PCT patents related to the encapsulation of bioactive compounds and probiotic microorganisms and has published different scientific papers on the field.
LINE 2. DEVELOPMENT OF NEW PRODUCTS, PROCESSES AND PACKAGING
New product innovations and reformulation "from the production line to the supermarket shelf". Formulation of ingredients, processing and preservation technologies, packaging and labelling.
CNTA can work on the design, formulation and scale-up of new or improved food formulations, in terms of nutrient composition, shelf life, etc.
In addition, CNTA can study of the technical and economic viability of the processes for scale-up and industrialisation.
LINE 3. NOVEL FOOD PROCESSING
Application of novel food processing technologies for developing new products or improving the quality of the existing ones (sensory, nutritional, and shelf life).
Study and optimisation of different processing technologies including High Hydrostatic Pressure Processing (HPP), Pulsed Electric Fields (PEF), Radio Frequency (RF). Novel sanitising agents and food preservatives as alternatives to conventional treatment and preservation technologies.
LINE 4. INDUSTRIAL BIOTECHNOLOGY
Characterisation, optimisation and control of fermentation processes : bakery, vinegar, dairy, meat and brewery sectors.
Development of novel compounds, ingredients antioxidant, additives, colourants, thickeners, polymers, etc.) for the food, pharma and cosmetic sectors based on fermentative processes.
Development of new fermented foods and probiotics: Isolation, selection and characterisation of potential probiotic microorganisms and (new) fermentation starters . Characterisation of viable non-culturable microorganisms. Formulation of novel and potentially probiotic foods and advice on labelling regulatory framework.
Solutions available at pilot and industrial scales. They can be further developed according to the needs of the customer
LINE 5 . SUSTAINABLE FOOD PRODUCTION
Resource efficiency: using new technologies to reduce processing costs (inputs).
Processing for improved mass transfer: pre- treatment of raw materials for the enhanced recovery of valuable compounds.
Sustainability of the Food Chain: strategies to minimise and food waste and or limit loss.
Valorisation: approaches for processing agro-industrial wastes and by-products for their conversion in high-value products. Industrial feasibility studies.
Projects
CIMA
• CITTIL - Cooperación para la Investigación Transpirenaica en la Terapia Innovadora de la Leucemia.
• AIPGENE: Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria
• CANCERLINC: Functional and Mechanistic Roles of large Intergenic Non-coding RNAs in Cancer.
• THOVLEN: Targeted Herpesvirus-derived Oncolytic Vectors for Liver Cancer European Network
• HIVSTOP: Development of an effective RNA interference-based anti-HIV-1 therapy using an SV40-derived gene transfer vector
• Ingenious HyperCare: Integrating Genomics, Clinical Research and Care in Hypertension
• ENCITE: Imaging of cellular therapy and therapeutic effects
• REPLACES: Restorative Plasticity At Corticostriatal Excitatory.
• BRAINCAV: Nonhuman adenovirus vectors for gene transfer to the Brain
• IMMUNONET: Red de Inmunoterapia
• IMMUNONET is the first EUROPEAN IMMUNOTHERAPY NETWORK. The project was designed to foster the collaboration among leading research institutions in the SUDOE area (Spain, France and Portugal).
• HETEROPARK:Synthesis and validation of antiparkinsonian drugs targeting GPCR heteromers
• HETEROPARK is a translational Project devoted to develop a novel therapeutic strategy to combat Parkinson’s disease (PD) symptoms and the treatment of Levodopa-induced dyskinesias (LIDs) by targeting G-proteincoupled receptor heterodimers.
• CURELUNG: Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis
• HEPACUTE: Host and viral factors in acute hepatitis C
• MEDIA: The MEtabolic Road to DIAstolic Heart Failure
• EU-MASCARA: Evaluation and validation studies of clinically useful biomarkers in prevention and management of cardiovascular diseases
• BRAINVECTORS: from Brain Gene Transfer towards Gene Therapy: Pharmacological Assessment of AAV, CAV-2 and LVV
• PROTEA: Influence of proteases before, during and after stroke
• HOMAGE:Heart OMics in AGEing
• IACT: Immunostimulatory Agonist antibodies for Cancer Therapy
• FIBROTARGETS: Targeting cardiac fibrosis for heart failure treatment
• The Fibro-Targets project is a multi-disciplinary 4 years program involving 10 partners ambitioning “the identification, characterisation and validation of in vitro and in vivo models of novel therapeutically relevant targets” for myocardial interstitial fibrosis (MIF) in heart failure.
• RNATrain: The European non-coding RNA training network
• ReproPark: New experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming
NAVARRABIOMED
• FIBROTARGETS, proyecto colaborativo financiado por el 7º Programa Marco.
• ADMIRE financiado por COST Action en el 7ª Programa Marco, participación en red para el fomento de proyectos colaborativos y captación de fondos.
• REFBIO, Red transfronteriza de investigación biomédica liderada por la FMS y financiada por el Programa de Cooperación Territorial España, Francia, Andorra. En su segundo año de actividad, además de crear una plataforma online al servicio de los investigadores, ha promovido y dotado económicamente a 17 proyectos de investigación con miembros de la red. Investigadores del SNS-O y Navarrabiomed participan en 8 de los proyectos financiados. www.refbio.eu
• JAMIE- Joint Action for Monitoring Injuries in Europe ha conseguido con éxito la implantación de un Sistema de Vigilancia Epidemiológica de accidentes en el Servicio de Urgencias del CHNA.
• Eiffel – Proyecto financiado por la eranet Eurotransbio y cuyo objetivo es la detección temprana de infecciones fúngicas invasivas mediante sensores de Terahercios.
CNTA
• Selection and improving of fit-for-purpose sampling procedures for specific foods and risks (BASELINE) www.baselineeurope.eu . 7th FWP. Research area: KBBE-2007-2-4-05 Food sampling strategies for risk analysis
• BioTRANSformation of by-products from fruit and vegetable processing industry into valuable BIOproducts (TRANSBIO), http://www.transbio.eu , 7th FWP , Research area: KBBE.2011.3.4-01 BioWASTE - Novel biotechnological approaches for transforming industrial and/or municipal biowaste into bioproducts – SICA
• RESFOOD - RESOURCE EFFICIENT AND SAFE FOOD PRODUCTION AND PROCESSING, From 2012-11-01 to 2015-10-31 | RESFOOD http://www.resfood.eu
• CARbohydrate derived BIOpolymers – an innovative conversion strategy for vegetable by-products. www.carbio.net
CEMITEC
• ENVIGUARD.Developmentofabiosensortechnologyforenvironmentalmonitoringanddiseasepreventioninaquacultureensuringfoodsafety.StartedJanuary2014(ongoing).http://www.enviguard.net/
• SUSFOFLEX.Smartandsustainablefoodpackagingutilizingflexibleprintedintelligenceandmaterialstechnologies.FP7.StartedJanuary2012(ongoing).www.susfoflex.com
• NANOSELECT.Functionalmembranes/filterswithanti/low-foulingsurfacesforwaterpurificationthroughselectiveadsorptiononbiobasednanocrystalsandfibrils.FP7.StartedFebruary2012(ongoing).www.nanoselect.eu
• Integraluseofoilseedstoreducegreenhousegasesemissionsassociatedwithfarmingactivitiesoilseedscanbeusedtoobtainbiofuelsandfeedstuffsforlivestock.LIFE.StartedSeptember2013(ongoing).http://lifeseedcapital.eu/en
• Sustainablecommunitythroughtheproductionof30.000Tm/yearofbiodieselstartingfromsunflower,rapeseedandpalmbiomass.FP6.2002-2005.
CENER- Biomasa
• LOGISTEC (2012—2016) “Logistics for Energy Crops”. FP7 EU-KBBE work program - CENER participates coordinating the demonstration work package devoted to implement research advancements into different case studies.
• SECTOR (2012-2015) “Supporting market introduction of torrefied products as solid sustainable energy carrier”. FP7 EU Energy work program. CENER brings in its technical know-how and infrastructures in the two main technologies covered by this project: Torrefaction and Densification.
• VALUE (2011-2013) “Exchange and technology transfer for waste recovery vegetables transformed industry in SUDOE”. Interreg IVb SUDOE. CENER participates developing energy based valuating processes from transformed vegetables industry wastes, mainly by means of ethanol production.
• BUTANOL (2010-2012) “Evaluation of butanol production and use in gasoline blends”. Government of Navarra: Technological Pole Projects. CENER coordinates the project and participates in the development of butanol production process at laboratory scale.
• ENERGREEN (2012-2014) “Overcoming barriers to the development of cultures of microalgae for bioenergy purposes”. Interreg IVa POCTEFA. CENER develops extraction activities, characterization and valuation of oil produced by the microalgae
• MULTIBIOM (2013-2014) “Development of Multi-fuel Biomass Combustion Technology for High power electricity production”. Innpacto (MINECO – Spain). CENER develops a methodology for the prediction of inorganic and ash fraction behaviour in Biomass combustion processes aiming to optimize boilers design and operation
Permalink: http://www.mercadosbiotecnologicos.com/?eid=266&etid=4&lan=en

Search